About
Life Science Angels is a Silicon Valley-based angel investor group exclusively focused on early-stage life science and biotech startups. The group operates as a curated network of accredited investors providing capital, mentorship, and industry connections to health-tech and life science founders navigating the critical seed and Series A stages. Rather than pursuing broad diversification across technology sectors, the organization has adopted a vertical specialization strategy, concentrating expertise and deal flow in the life sciences domain where regulatory complexity, clinical validation timelines, and scientific rigor create meaningful barriers to entry for generalist investors. This sector focus allows the group to develop deep domain expertise, cultivate relationships with life science entrepreneurs, and create value-add beyond capital deployment. Members gain access to a curated pipeline of pre-screened life science opportunities, peer learning through deal reviews and industry events, and the collective experience of investors who understand FDA pathways, clinical trial structures, and the specific capital requirements that distinguish biotech from traditional software ventures. Portfolio companies receive not only funding but also introductions to potential customers, scientific advisors, business development contacts, and subsequent funding sources within the venture capital ecosystem. The organization positions itself as a bridge between aspiring biotech founders and institutional venture investors, operating within the traditional angel investment model of smaller check sizes at earlier stages than institutional VCs. The group's singular focus on life sciences—rather than the broader angel model covering multiple sectors—reflects a thesis that specialized expertise and concentrated industry knowledge drive superior outcomes in one of healthcare's most capital-intensive and scientifically demanding sectors.